Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

High rye bourbons stole the show at BTI 2025, with 11 Gold Medals. Bold, spicy, and complex, these whiskeys prove why ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

“KPop Demon Hunters” made me sigh with relief: Hybrids, mash-ups, whatever you want to call it, are no longer a freak show ...

The 79th Independence Day was celebrated with great joy and enthusiasm at Udupi City Centre Mall on Friday Aug 15. The flag ...

Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver ...

Plainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first and ...

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...